A phase II trial of marimastat in advanced pancreatic cancer. by Evans, J, Stark, A, Johnson, C, Daniel, F, Carmichael, J, Buckels, J, Imrie, C, Brown, P, Neoptolemos, J

Pancreatic cancer susceptibility loci and their role in survival by Rizzato, C, Campa, D, Giese, N, Werner, J, Rachakonda, P, Kumar, R, Schanné, M, Greenhalf, W, Costello, E, Khaw, K, Key, T, Siddiq, A, Lorenzo-Bermejo, J, Burwinkel, B, Neoptolemos, J, Büchler, M, Hoheisel, J, Bauer, A, Canzian, F

Pancreatic cancer susceptibility loci and their role in survival by Rizzato, C, Campa, D, Giese, N, Werner, J, Rachakonda, P, Kumar, R, Schanné, M, Greenhalf, W, Costello, E, Khaw, K, Key, T, Siddiq, A, Lorenzo-Bermejo, J, Burwinkel, B, Neoptolemos, J, Büchler, M, Hoheisel, J, Bauer, A, Canzian, F

Periampullary Cancer ESPAC-3(v2) trial: a Randomised Controlled Phase III Trial of Adjuvant Chemotherapy Versus Observation in Patients With Periampullary Adenocarcinomas of the He... by Neoptolemos, J, Moore, M, Cox, T, Valle, J, Palmer, D, Mcdonald, A, Carter, R, Tebbutt, N, Dervenis, C, Smith, D, Glimelius, B, Coxon, F, Lacaine, F, Middleton, M, Ghaneh, P, Bassi, C, Halloran, C, Olah, A, Rawcliffe, C, Buechler, M

Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 pe... by Neoptolemos, J, Moore, M, Cox, T, Valle, J, Palmer, D, McDonald, A, Carter, R, Tebbutt, N, Dervenis, C, Smith, D, Glimelius, B, Charnley, R, Lacaine, F, Scarfe, A, Middleton, MR, Anthoney, A, Ghaneh, P, Halloran, C, Lerch, M, Oláh, A, Rawcliffe, C, Verbeke, C, Campbell, F, Büchler, M

ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium. by Rizzato, C, Campa, D, Pezzilli, R, Soucek, P, Greenhalf, W, Capurso, G, Talar-Wojnarowska, R, Heller, A, Jamroziak, K, Khaw, K, Key, T, Bambi, F, Landi, S, Mohelnikova-Duchonova, B, Vodickova, L, Büchler, M, Bugert, P, Vodicka, P, Neoptolemos, J, Werner, J, Hoheisel, J, Bauer, A, Giese, N, Canzian, F

Lack of replication of seven pancreatic cancer susceptibility loci identified in two Asian populations. by Campa, D, Rizzato, C, Bauer, A, Werner, J, Capurso, G, Costello, E, Talar-Wojnarowska, R, Jamroziak, K, Pezzilli, R, Gazouli, M, Khaw, K, Key, T, Bambi, F, Mohelnikova-Duchonova, B, Heller, A, Landi, S, Vodickova, L, Theodoropoulos, G, Bugert, P, Vodicka, P, Hoheisel, J, Delle Fave, G, Neoptolemos, J, Soucek, P, Büchler, M

Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial. by Greenhalf, W, Ghaneh, P, Neoptolemos, J, Palmer, D, Cox, T, Lamb, R, Garner, E, Campbell, F, Mackey, JR, Costello, E, Moore, M, Valle, J, McDonald, A, Carter, R, Tebbutt, N, Goldstein, D, Shannon, J, Dervenis, C, Glimelius, B, Deakin, M, Charnley, R, Lacaine, F, Scarfe, A, Middleton, MR, Anthoney, A

Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk. by Campa, D, Pastore, M, Gentiluomo, M, Talar-Wojnarowska, R, Kupcinskas, J, Malecka-Panas, E, Neoptolemos, J, Niesen, W, Vodicka, P, Delle Fave, G, Bas Bueno-de-Mesquita, H, Gazouli, M, Pacetti, P, Di Leo, M, Ito, H, Klüter, H, Soucek, P, Corbo, V, Yamao, K, Hosono, S, Kaaks, R, Vashist, Y, Gioffreda, D, Strobel, O, Shimizu, Y, Dijk, F, Andriulli, A, Ivanauskas, A, Bugert, P, Tavano, F, Vodickova, L, Federico Zambon, C, Lovecek, M, Landi, S, Key, T, Boggi, U, Pezzilli, R, Jamroziak, K, Mohelnikova-Duchonova, B, Mambrini, A, Bambi, F, Busch, O, Pazienza, V, Valente, R, Theodoropoulos, G, Hackert, T, Capurso, G, Martina Cavestro, G, Pasquali, C, Basso, D, Sperti, C, Matsuo, K, Büchler, M, Khaw, K, Izbicki, J, Costello, E, Katzke, V, Michalski, C, Stepien, A, Rizzato, C, Canzian, F